FDC Limited (BOM:531599)
India · Delayed Price · Currency is INR 342.65
+1.05 (0.31%)
At close: Sep 4, 2026
FDC Limited Market Cap
FDC Limited has a market cap or net worth of 55.79 billion as of September 4, 2026. Its market cap has decreased by -26.15% in one year.
Market Cap
55.79B
Enterprise Value
50.71B
Revenue
21.90B
Ranking
n/a
PE Ratio
19.06
Stock Price
342.65
ChartMarket Cap Chart
Since May 30, 2002, FDC Limited's market cap has increased from 2.73B to 55.79B, an increase of 1,945.32%. That is a compound annual growth rate of 13.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 55.79B | -19.05% |
| Dec 31, 2025 | 68.92B | -15.14% |
| Dec 31, 2024 | 81.22B | 25.96% |
| Dec 29, 2023 | 64.48B | 43.15% |
| Dec 30, 2022 | 45.04B | -12.27% |
| Dec 31, 2021 | 51.34B | -8.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viyash Scientific | 115.84B |
| Procter & Gamble Health | 93.92B |
| Sanofi India | 72.55B |
| Bliss GVS Pharma | 71.07B |
| Morepen Laboratories | 62.30B |
| Gufic Biosciences | 44.67B |
| Novartis India | 40.42B |
| Unichem Laboratories | 38.79B |